An approach to assess quality of life through biometric monitoring in cancer patients

Abstract

Cancer is a serious disease that causes significant disability and suffering, so naturally Health Related Quality of Life (HRQoL) is a major concern of patients, families and clinicians. This paper intends to relate biometric indices, in terms of HRV metrics, with self-perceived HRQoL from patients with lymphoma. Patients (N = 12) answered FACT questionnaire and used a smartband that collected biometrical data in real-time along the chemotherapy treatment. Our results revealed that Physical Well-Being, Total, Lymphoma subscale and FACT-Lym Trial Outcome domains seem to have a similar pattern that HRV metrics across the treatment cycles. In specific, the FACT domains and the HRV metrics have the lowest average levels on the first cycle and seem to increase along the following cycles (3rd and 6th cycles). This approach of continuous assessment of HRQoL will enable a better accuracy and more supported clinical decision.